Review Evidence Strength and Expansion Readiness
Stress-test the entry plan against critical assumptions regarding US buyer demand, legal compliance, and capital burn. Validate whether customer commitments and regulatory clearances are backed by binding agreements or empirical evidence.
Conducting a rigorous quality review prevents premature market entry based on unverified assumptions or weak lead pipelines. It maximises the venture's chances of success by exposing operational and financial risks prior to execution.
Produce a risk matrix and evidence scorecard rating the strength of buyer validation, legal readiness, partner commitment, and financial allocation. Document clear mitigation steps for any low-confidence areas identified.
Five questions an expert would ask when reviewing your output
Use these to challenge assumptions, pressure-test your logic, and check the quality of this action's output in the context of the parent task and wider venture development.
- 1
What proportion of your US pipeline consists of signed letters of intent versus informal, non-binding interest?
- 2
How thoroughly have you stress-tested your financial runway against a scenario where US sales cycles take twice as long as planned?
- 3
What independent legal or regulatory expert opinion backs your assumptions regarding compliance in target states?
- 4
Where are the weakest links in your partner strategy, and what trigger signals an immediate pivot in channel approach?
- 5
Is the decision to proceed based on verifiable market pull or internal operational push from domestic market saturation?